spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  ghrelin agonist 

 HSMN NewsFeed - 27 Oct 2014
Aeterna Zentaris Announces Formal Implementation of its Sales Force In Support of Selling ASCEND's EstroGel(R)
Biopharmaceuticals Distribution
 HSMN NewsFeed - 5 Aug 2014
Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market
Biopharmaceuticals Distribution
 HSMN NewsFeed - 27 Nov 2012
Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Jun 2012
Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
Biopharmaceuticals Endocrinology Venture Capital
 HSMN NewsFeed - 18 Oct 2011
Tranzyme Pharma Names Former Gilead Executive Franck Rousseau, M.D. Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Dec 2010
Tranzyme Pharma Appoints Pharmaceutical Industry Veteran John H. Johnson as Chairman of its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2010
Rhythm Closes $40 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Jun 2010
Tranzyme Pharma and Norgine Sign License Agreement for Late-Stage Development Product, Ulimorelin (TZP-101), in Europe and Other Select Regions
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 May 2010
Tranzyme Pharma Presents Data Demonstrating that TZP-101 (Ulimorelin) Restores Bowel Function in Patients with Postoperative Ileus (POI) Regardless of the Extent of Opioid Use
Biopharmaceuticals
 HSMN NewsFeed - 18 Dec 2009
Aeterna Zentaris Announces Termination of Agreement with sanofi-aventis U.S. for the Development, Commercialization and Licensing of Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 7 Dec 2009
AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 6 May 2008
Tranzyme Pharma Strengthens Clinical Development Team With the Appointment of Philippa A. Charlton, MD, MPH as Medical Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2007
Elixir Pharmaceuticals Names Paul M. Martha, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Aug 2007
Elixir Pharmaceuticals Initiates Final Phase III Clinical Study Prior to NDA
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 29 Jan 2007
Elixir Pharmaceuticals Names Gregory D. Perry as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jan 2007
Elixir Pharmaceuticals Presents New Data Highlighting Ghrelin Inhibition as a Potential Method for Regulating Metabolism and Treating Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 28 Nov 2006
Elixir Pharmaceuticals Raises $46 Million
Biopharmaceuticals Venture Capital
Return to NewsFeed  

 Additional items found! 4

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 4 additional stories matching:
ghrelin agonist
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!